Padeliporfin Recruiting Phase 3 Trials for Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04620239ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study